These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 22870331)
1. Canine hepacivirus NS3 serine protease can cleave the human adaptor proteins MAVS and TRIF. Parera M; Martrus G; Franco S; Clotet B; Martinez MA PLoS One; 2012; 7(8):e42481. PubMed ID: 22870331 [TBL] [Abstract][Full Text] [Related]
2. Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission. Anggakusuma ; Brown RJP; Banda DH; Todt D; Vieyres G; Steinmann E; Pietschmann T J Virol; 2016 Dec; 90(23):10670-10681. PubMed ID: 27654291 [TBL] [Abstract][Full Text] [Related]
3. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense. Johnson CL; Owen DM; Gale M J Biol Chem; 2007 Apr; 282(14):10792-803. PubMed ID: 17289677 [TBL] [Abstract][Full Text] [Related]
4. Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes. Dansako H; Ikeda M; Kato N FEBS J; 2007 Aug; 274(16):4161-76. PubMed ID: 17651439 [TBL] [Abstract][Full Text] [Related]
5. GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS. Chen Z; Benureau Y; Rijnbrand R; Yi J; Wang T; Warter L; Lanford RE; Weinman SA; Lemon SM; Martin A; Li K J Virol; 2007 Jan; 81(2):964-76. PubMed ID: 17093192 [TBL] [Abstract][Full Text] [Related]
6. Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0. Horner SM; Park HS; Gale M J Virol; 2012 Mar; 86(6):3112-20. PubMed ID: 22238314 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus NS3-4A inhibits the peroxisomal MAVS-dependent antiviral signalling response. Ferreira AR; Magalhães AC; Camões F; Gouveia A; Vieira M; Kagan JC; Ribeiro D J Cell Mol Med; 2016 Apr; 20(4):750-7. PubMed ID: 26865163 [TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease. Ferreon JC; Ferreon AC; Li K; Lemon SM J Biol Chem; 2005 May; 280(21):20483-92. PubMed ID: 15767257 [TBL] [Abstract][Full Text] [Related]
9. Double-stranded RNA-induced interferon-beta and inflammatory cytokine production modulated by hepatitis C virus serine proteases derived from patients with hepatic diseases. Dansako H; Ikeda M; Ariumi Y; Wakita T; Kato N Arch Virol; 2009; 154(5):801-10. PubMed ID: 19353241 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavage. Welsch C; Haselow K; Gouttenoire J; Schneider M; Morikawa K; Martinez Y; Susser S; Sarrazin C; Zeuzem S; Antes I; Moradpour D; Lange CM J Hepatol; 2015 Apr; 62(4):779-84. PubMed ID: 25463536 [TBL] [Abstract][Full Text] [Related]
11. Extended interaction networks with HCV protease NS3-4A substrates explain the lack of adaptive capability against protease inhibitors. Dultz G; Shimakami T; Schneider M; Murai K; Yamane D; Marion A; Zeitler TM; Stross C; Grimm C; Richter RM; Bäumer K; Yi M; Biondi RM; Zeuzem S; Tampé R; Antes I; Lange CM; Welsch C J Biol Chem; 2020 Oct; 295(40):13862-13874. PubMed ID: 32747444 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Li XD; Sun L; Seth RB; Pineda G; Chen ZJ Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17717-22. PubMed ID: 16301520 [TBL] [Abstract][Full Text] [Related]
13. Differential, type I interferon-mediated autophagic trafficking of hepatitis C virus proteins in mouse liver. Desai MM; Gong B; Chan T; Davey RA; Soong L; Kolokoltsov AA; Sun J Gastroenterology; 2011 Aug; 141(2):674-85, 685.e1-6. PubMed ID: 21683701 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression. Kaukinen P; Sillanpää M; Kotenko S; Lin R; Hiscott J; Melén K; Julkunen I Virol J; 2006 Sep; 3():66. PubMed ID: 16945160 [TBL] [Abstract][Full Text] [Related]
15. Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus. Morikawa K; Lange CM; Gouttenoire J; Meylan E; Brass V; Penin F; Moradpour D J Viral Hepat; 2011 May; 18(5):305-15. PubMed ID: 21470343 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A. Vazquez C; Tan CY; Horner SM J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039 [TBL] [Abstract][Full Text] [Related]
17. Recruitment of an interferon molecular signaling complex to the mitochondrial membrane: disruption by hepatitis C virus NS3-4A protease. Hiscott J; Lacoste J; Lin R Biochem Pharmacol; 2006 Nov; 72(11):1477-84. PubMed ID: 16876765 [TBL] [Abstract][Full Text] [Related]
18. Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage. Qian S; Fan W; Liu T; Wu M; Zhang H; Cui X; Zhou Y; Hu J; Wei S; Chen H; Li X; Qian P J Virol; 2017 Aug; 91(16):. PubMed ID: 28566380 [TBL] [Abstract][Full Text] [Related]
19. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Li K; Foy E; Ferreon JC; Nakamura M; Ferreon AC; Ikeda M; Ray SC; Gale M; Lemon SM Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2992-7. PubMed ID: 15710891 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity. Ding Q; Cao X; Lu J; Huang B; Liu YJ; Kato N; Shu HB; Zhong J J Hepatol; 2013 Jul; 59(1):52-8. PubMed ID: 23542348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]